Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy

Breast Cancer Research and Treatment

Volumn 154, Issue 1, 2015, Pages 127-132

  Arpino, Grazia ^a   De Angelis, Carmine ^a   Buono, Giuseppe ^a   Colao, Annamaria ^a   Giuliano, Mario ^a   Malgieri, Simona ^a   Cicala, Stefania ^a   De Laurentiis, Michelino ^b   Accurso, Antonello ^a   Crispo, Anna ^b   Limite, Gennaro ^a   Lauria, Rossella ^a   Veneziani, Bianca Maria ^a   Forestieri, Valeria ^a   Bruzzese, Dario ^a   De Placido, Sabino ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Adjuvant therapy; Body weight and composition; Breast cancer; Glucose and lipid metabolism; Menopausal status

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; LIPID;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; BREAST CANCER; CANCER ADJUVANT THERAPY; CHOLESTEROL BLOOD LEVEL; EARLY CANCER; FEMALE; GLUCOSE BLOOD LEVEL; HIP CIRCUMFERENCE; HUMAN; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC REGULATION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; TUMOR VOLUME; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; BREAST NEOPLASMS; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; POSTMENOPAUSE;

ADULT; BLOOD GLUCOSE; BODY FAT DISTRIBUTION; BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; INSULIN; LIPIDS; MIDDLE AGED; OBESITY; POSTMENOPAUSE; TRIGLYCERIDES; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84945493076     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-015-3586-x     Document Type: Article

References (34)

1. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Taylor SK, Hood N (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol 30(2):164–171. doi:10.1200/JCO.2011.36.2723
2. Vatten LJ, Foss OP (1990) Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res 50(8):2341–2346
3. Smethurst M, Basu TK, Williams DC (1975) Levels of cholesterol, 11-hydroxycorticosteroids and progesterone in plasma from postmenopausal women with breast cancer. Eur J Cancer 11(10):751–755
4. Key T, Appleby P, Barnes I, Reeves G, Endogenous H, Breast Cancer Collaborative G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8):606–616
5. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH (1990) Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 8(8):1327–1334
6. Chlebowski RT, Weiner JM, Reynolds R, Luce J, Bulcavage L, Bateman JR (1986) Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 7(1):23–30
7. Goodwin PJ, Panzarella T, Boyd NF (1988) Weight gain in women with localized breast cancer–a descriptive study. Breast Cancer Res Treat 11(1):59–66
8. Heasman KZ, Sutherland HJ, Campbell JA, Elhakim T, Boyd NF (1985) Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 5(2):195–200
9. Levine EG, Raczynski JM, Carpenter JT (1991) Weight gain with breast cancer adjuvant treatment. Cancer 67(7):1954–1959
10. Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, Stefanick ML, Faerber S, Pierce JP (1999) Factors associated with weight gain in women after diagnosis of breast cancer. Women’s Healthy Eating and Living Study Group. J Am Diet Assoc 99(10):1212–1221
11. Costa LJ, Varella PC, del Giglio A (2002) Weight changes during chemotherapy for breast cancer. Sao Paulo Med J 120(4):113–117
12. Vagenas D, DiSipio T, Battistutta D, Demark-Wahnefried W, Rye S, Bashford J, Pyke C, Saunders C, Hayes SC (2015) Weight and weight change following breast cancer: evidence from a prospective, population-based, breast cancer cohort study. BMC Cancer 15(1):28. doi:10.1186/s12885-015-1026-2
13. Rodrigues Dos Santos C, Fonseca I, Dias S, Mendes de Almeida JC (2014) Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression. BMC Cancer 14:132. doi:10.1186/1471-2407-14-132
14. Bjorntorp P (1987) Fat cell distribution and metabolism. Ann N Y Acad Sci 499:66–72
15. Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, Sidlofsky S, Trudeau M, Hood N, Redwood S (1999) Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 17(1):120–129
16. Kroenke CH, Chen WY, Rosner B, Holmes MD (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23(7):1370–1378. doi:10.1200/JCO.2005.01.079
17. Nichols HB, Trentham-Dietz A, Egan KM et al (2009) Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarker Prev 18:1403–1409
18. Heideman WH, Russell NS, Gundy C, Rookus MA, Voskuil DW (2009) The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors. Eur J Cancer 45(1):119–126. doi:10.1016/j.ejca.2008.09.003
19. Saquib N, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, Caan B, Rock CL, Pierce JP (2007) Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women’s healthy eating and living (WHEL) study. Breast Cancer Res Treat 105(2):177–186. doi:10.1007/s10549-006-9442-2
20. Tredan O, Bajard A, Meunier A, Roux P, Fiorletta I, Gargi T, Bachelot T, Guastalla JP, Lallemand Y, Faure C, Perol D, Bachmann P (2010) Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study. Clin Nutr 29(2):187–191. doi:10.1016/j.clnu.2009.08.003
21. Gu K, Chen X, Zheng Y, Chen Z, Zheng W, Lu W, Shu XO (2010) Weight change patterns among breast cancer survivors: results from the Shanghai breast cancer survival study. Cancer Causes Control 21(4):621–629. doi:10.1007/s10552-009-9491-z
22. Thivat E, Therondel S, Lapirot O, Abrial C, Gimbergues P, Gadea E, Planchat E, Kwiatkowski F, Mouret-Reynier MA, Chollet P, Durando X (2010) Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer 10:648. doi:10.1186/1471-2407-10-648
23. Xiaoli Chen WL, Kai G, Chen Zhi, Zheng Ying, Zheng Wei, Shu Xiao Ou (2011) Weight change and its correlates among breast cancer survivors. Nutr Cancer 63(4):538–548. doi:10.1080/01635581.2011.539316
24. Caan BJ, Kwan ML, Hartzell G, Castillo A, Slattery ML, Sternfeld B, Weltzien E (2008) Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control 19(10):1319–1328. doi:10.1007/s10552-008-9203-0
25. Demark-Wahnefried W, Winer EP, Rimer BK (1993) Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 11(7):1418–1429
26. Irwin ML, McTiernan A, Baumgartner RN, Baumgartner KB, Bernstein L, Gilliland FD, Ballard-Barbash R (2005) Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncology 23(4):774–782. doi:10.1200/JCO.2005.04.036
27. Han HS, Lee KW, Kim JH, Kim SW, Kim IA, Oh DY, Im SA, Bang SM, Lee JS (2009) Weight changes after adjuvant treatment in Korean women with early breast cancer. Breast Cancer Res Treat 114(1):147–153. doi:10.1007/s10549-008-9984-6
28. Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, Marcom PK, Blackwell K, Rimer BK (2001) Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19(9):2381–2389
29. Harvie MN, Campbell IT, Baildam A, Howell A (2004) Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 83(3):201–210. doi:10.1023/B:BREA.0000014037.48744.fa
30. Aslani A, Smith RC, Allen BJ, Pavlakis N, Levi JA (1999) Changes in body composition during breast cancer chemotherapy with the CMF-regimen. Breast Cancer Res Treat 57(3):285–290
31. Freedman RJ, Aziz N, Albanes D, Hartman T, Danforth D, Hill S, Sebring N, Reynolds JC, Yanovski JA (2004) Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metabol 89(5):2248–2253. doi:10.1210/jc.2003-031874
32. Campbell KL, Lane K, Martin AD, Gelmon KA, McKenzie DC (2007) Resting energy expenditure and body mass changes in women during adjuvant chemotherapy for breast cancer. Cancer Nurs 30(2):95–100. doi:10.1097/01.NCC.0000265004.64440.5f
33. Kutynec CL, McCargar L, Barr SI, Hislop TG (1999) Energy balance in women with breast cancer during adjuvant treatment. J Am Diet Assoc 99(10):1222–1227
34. Hiona A, Lee AS, Nagendran J, Xie X, Connolly AJ, Robbins RC, Wu JC (2011) Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function. J Thoracic Cardiovas Surg 142(2):396–403